HomeBALPHARMA • NSE
add
Bal Pharma Ltd
Previous close
₹134.50
Day range
₹133.00 - ₹140.95
Year range
₹88.95 - ₹157.98
Market cap
2.20B INR
Avg Volume
16.91K
P/E ratio
28.63
Dividend yield
0.87%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 736.94M | -20.37% |
Operating expense | 304.84M | -10.21% |
Net income | 10.42M | 10.17% |
Net profit margin | 1.41 | 38.24% |
Earnings per share | — | — |
EBITDA | 76.71M | 1.59% |
Effective tax rate | 23.48% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 247.15M | 194.95% |
Total assets | 3.40B | 2.93% |
Total liabilities | 2.71B | 1.54% |
Total equity | 687.58M | — |
Shares outstanding | 16.03M | — |
Price to book | 3.13 | — |
Return on assets | — | — |
Return on capital | 6.03% | — |
Cash Flow
Net change in cash
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 10.42M | 10.17% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1987
Website
Employees
868